Does HEPATITIS A VIRUS STRAIN HM175 ANTIGEN \HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Cause Headache? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Headache have been filed in association with HEPATITIS A VIRUS STRAIN HM175 ANTIGEN \HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN. This represents 26.3% of all adverse event reports for HEPATITIS A VIRUS STRAIN HM175 ANTIGEN \HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN.
How Dangerous Is Headache From HEPATITIS A VIRUS STRAIN HM175 ANTIGEN \HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN?
Of the 5 reports, 3 (60.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Headache Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HEPATITIS A VIRUS STRAIN HM175 ANTIGEN \HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN. However, 5 reports have been filed with the FAERS database.